SCHEMBL1571096

SCHEMBL1571096

C[C@H](C=O)N(NCCOc1cc(Nc2ncc3cc(C#C[Si](C)(C)C)ccc3n2)cc(-c2cnn(C)c2)c1)C(=O)OC(C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR4 P22455 1/20 0.32
▸ GSK3B P49841 1/20 0.32
▸ DYRK1A Q13627 1/20 0.32
▸ TYRO3 Q06418 1/20 0.32
▸ MERTK Q12866 1/20 0.32
▸ DDR2 Q16832 8/20 0.31
▸ MAP4K3 Q8IVH8 1/20 0.31
▸ MAP4K1 Q92918 1/20 0.31
▸ TTK P33981 4/20 0.31
▸ CCNA2 P20248 3/20 0.31
▸ CDK2 P24941 3/20 0.31
▸ MAPK8 P45983 1/20 0.31
▸ MAPK9 P45984 1/20 0.31
▸ CCNK O75909 1/20 0.30
▸ CDK12 Q9NYV4 1/20 0.30
▸ GABRA1 P14867 1/20 0.30
▸ GABRG2 P18507 1/20 0.30
▸ GABRB3 P28472 1/20 0.30
▸ GABRA5 P31644 1/20 0.30
▸ GABRA3 P34903 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1571094 1.00 FGFR4 (0.32) FGFR4GSK3BDYRK1ATYRO3MERTK
SCHEMBL1571748 0.92 DDR2 (0.33) TYRO3MERTKDDR2MAP4K3MAP4K1
SCHEMBL1571351 0.86 GSK3B (0.39) GSK3BDYRK1ATYRO3MERTKDDR2
SCHEMBL1571670 0.84 GSK3B (0.35) GSK3BDYRK1ATYRO3MERTKDDR2
SCHEMBL1573257 0.84 GSK3B (0.35) GSK3BDYRK1ATYRO3MERTKDDR2
SCHEMBL1573258 0.84 GSK3B (0.35) GSK3BDYRK1ATYRO3MERTKDDR2
SCHEMBL1572814 0.82 GSK3B (0.38) GSK3BDYRK1ATYRO3MERTKDDR2
SCHEMBL1572812 0.82 GSK3B (0.38) GSK3BDYRK1ATYRO3MERTKDDR2
SCHEMBL1571672 0.82 GSK3B (0.38) GSK3BDYRK1ATYRO3MERTKDDR2
SCHEMBL1571675 0.81 BRAF (0.36) DDR2MAP4K3MAP4K1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307385-A1 2 -ARYLAMINOQUINAZOLINES FOR TREATING PROLIFERATIVE DISEASES Novartis AG (CH) 2011-04-13 — — EP disclosed
WO-2009153313-A1 2 -ARYLAMINOQUINAZOLINES FOR TREATING PROLIFERATIVE DISEASES NOVARTIS AG (CH) 2009-12-23 — — WO disclosed
Send feedback